HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jörg Zwirner Selected Research

Complement System Proteins (Complement)

10/2006Induction of C3 and CCL2 by C3a in keratinocytes: a novel autocrine amplification loop of inflammatory skin reactions.
3/2006Complement: a novel factor in basal and ischemia-induced neurogenesis.
3/2005Macrophages induce the inflammatory response in the pulmonary Arthus reaction through G alpha i2 activation that controls C5aR and Fc receptor cooperation.
9/2004C5a initiates the inflammatory cascade in immune complex peritonitis.
12/2002C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jörg Zwirner Research Topics

Disease

9Inflammation (Inflammations)
08/2007 - 12/2002
2Infections
03/2008 - 11/2007
2Asthma (Bronchial Asthma)
08/2007 - 03/2006
2Autoimmune Diseases (Autoimmune Disease)
08/2007 - 09/2004
2Pneumonia (Pneumonitis)
08/2007 - 03/2005
2Necrosis
04/2004 - 12/2003
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
09/2007
1Skin Diseases (Skin Disease)
10/2006
1Ischemia
03/2006
1Respiratory Hypersensitivity
03/2006
1Reperfusion Injury
02/2006
1Myocardial Ischemia (Ischemic Heart Diseases)
02/2006
1Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
02/2006
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
02/2006
1Arthus Reaction
03/2005
1Contact Dermatitis (Eczema, Contact)
02/2005
1Neoplasms (Cancer)
02/2005
1Peritonitis
09/2004
1Lung Diseases (Lung Disease)
12/2002

Drug/Important Bio-Agent (IBA)

6AnaphylatoxinsIBA
08/2007 - 12/2002
5Complement System Proteins (Complement)IBA
10/2006 - 12/2002
3Antigen-Antibody Complex (Immune Complex)IBA
03/2005 - 12/2002
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2005 - 12/2003
2AntigensIBA
03/2008 - 02/2005
2CytokinesIBA
03/2008 - 03/2006
2LipopolysaccharidesIBA
08/2007 - 12/2003
1Chemokine CCL21IBA
11/2007
1alpha-DefensinsIBA
09/2007
1Monoclonal AntibodiesIBA
08/2007
1OvalbuminIBA
08/2007
1Tryptases (Tryptase)IBA
10/2006
1Complement Factor B (Factor B)IBA
10/2006
1Proteins (Proteins, Gene)FDA Link
10/2006
1Complement Factor H (Factor H)IBA
10/2006
1Anaphylatoxin C5a ReceptorIBA
03/2006
1Complement C5 (Complement 5)IBA
03/2006
1AllergensIBA
03/2006
1AutoantibodiesIBA
02/2006
1Immunoglobulin G (IgG)IBA
02/2006
1Complement C5a (Complement 5a)IBA
02/2006
1Pertussis ToxinIBA
03/2005
1GTP-Binding Proteins (G-Protein)IBA
03/2005
1Fc Receptors (Fc Receptor)IBA
03/2005
1LigandsIBA
03/2005
1isothiocyanic acidIBA
02/2005
1OxazoloneIBA
02/2005
1Fluorescein-5-isothiocyanate (FITC)IBA
02/2005
1Fluorescein (Funduscein)FDA LinkGeneric
02/2005
1VaccinesIBA
02/2005
1Interferon-gamma (Interferon, gamma)IBA
12/2003
1CD40 Ligand (CD40L)IBA
12/2003
1Chemotactic FactorsIBA
12/2002

Therapy/Procedure

1Immunotherapy
02/2005
1Therapeutics
02/2005